A comprehensive view of Gene Therapy & Regenerative Medicine. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Charles River partners with Singapore's Yong Loo Lin School of Medicine to develop and manufacture plasmid DNA for engineered stem cell cancer therapy; partnership to use Charles River's CDMO expertise in HQ and GMP-compliant plasmid DNA

AGC Biologics to Manufacture First-ever FDA Approved Gene Therapy for Early-onset Metachromatic Leukodystrophy, Orchard Therapeutics’ Lenmeldy™ (atidarsagene autotemcel)

FDA Approves First Gene Therapy for Pediatric MLD from Orchard Therapeutics, and AGC Biologics Tapped to Manufacture It

Charles River Laboratories partners with Navega Therapeutics to produce gene therapy candidate NT-Z001 for Phase 1 clinical trials; the deal leverages Charles River's advisory services and contract development and manufacturing capabilities

Takeda is closing production at its gene therapy plant in Orth, Austria, resulting in nearly 200 job losses; despite attempts to sell the adeno-associated virus gene therapy facility, the Japan-based firm was unable to find a buyer

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count